DK164844C - Transdermalt effektivt topisk antiallergisk farmaceutisk middel indeholdende azatadin og anvendelse af azatadin til fremstilling af et saadant middel til topisk transdermal behandling af allergiske sygdomme - Google Patents

Transdermalt effektivt topisk antiallergisk farmaceutisk middel indeholdende azatadin og anvendelse af azatadin til fremstilling af et saadant middel til topisk transdermal behandling af allergiske sygdomme

Info

Publication number
DK164844C
DK164844C DK131586A DK131586A DK164844C DK 164844 C DK164844 C DK 164844C DK 131586 A DK131586 A DK 131586A DK 131586 A DK131586 A DK 131586A DK 164844 C DK164844 C DK 164844C
Authority
DK
Denmark
Prior art keywords
azatadin
topic
medicine
preparation
pharmaceutical composition
Prior art date
Application number
DK131586A
Other languages
Danish (da)
English (en)
Other versions
DK131586A (da
DK164844B (da
DK131586D0 (da
Inventor
Joel August Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK131586A publication Critical patent/DK131586A/da
Publication of DK131586D0 publication Critical patent/DK131586D0/da
Publication of DK164844B publication Critical patent/DK164844B/da
Application granted granted Critical
Publication of DK164844C publication Critical patent/DK164844C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK131586A 1984-07-23 1986-03-21 Transdermalt effektivt topisk antiallergisk farmaceutisk middel indeholdende azatadin og anvendelse af azatadin til fremstilling af et saadant middel til topisk transdermal behandling af allergiske sygdomme DK164844C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63354184A 1984-07-23 1984-07-23
US63354184 1984-07-23
US8501246 1985-07-01
PCT/US1985/001246 WO1986000806A1 (fr) 1984-07-23 1985-07-01 Administration transdermique d'azatadine

Publications (4)

Publication Number Publication Date
DK131586A DK131586A (da) 1986-03-21
DK131586D0 DK131586D0 (da) 1986-03-21
DK164844B DK164844B (da) 1992-08-31
DK164844C true DK164844C (da) 1993-01-11

Family

ID=24540048

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131586A DK164844C (da) 1984-07-23 1986-03-21 Transdermalt effektivt topisk antiallergisk farmaceutisk middel indeholdende azatadin og anvendelse af azatadin til fremstilling af et saadant middel til topisk transdermal behandling af allergiske sygdomme

Country Status (10)

Country Link
EP (1) EP0188538B1 (fr)
JP (1) JPS61502751A (fr)
AU (1) AU576884B2 (fr)
CA (1) CA1263602A (fr)
DE (1) DE3573532D1 (fr)
DK (1) DK164844C (fr)
IL (2) IL75853A0 (fr)
NZ (1) NZ212800A (fr)
WO (1) WO1986000806A1 (fr)
ZA (1) ZA855485B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422118A (en) * 1986-11-07 1995-06-06 Pure Pac, Inc. Transdermal administration of amines with minimal irritation and high transdermal flux rate
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
US4877618A (en) * 1988-03-18 1989-10-31 Reed Jr Fred D Transdermal drug delivery device
EP3558276A1 (fr) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Système thérapeutique transdermique contenant de l'asénapine et un polysiloxane ou un polyisobutylène
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
WO2019002204A1 (fr) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag Système thérapeutique transdermique contenant de l'asénapine et un polymère hybride acrylique de type silicone
WO2019243452A1 (fr) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Système thérapeutique transdermique contenant de l'asénapine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435114A (en) * 1965-11-08 1969-03-25 Mead Johnson & Co Topical antihistaminic compositions containing methdilazine sulfoxide

Also Published As

Publication number Publication date
NZ212800A (en) 1989-01-06
EP0188538B1 (fr) 1989-10-11
CA1263602A (fr) 1989-12-05
WO1986000806A1 (fr) 1986-02-13
DE3573532D1 (de) 1989-11-16
DK131586A (da) 1986-03-21
DK164844B (da) 1992-08-31
IL74853A (en) 1988-08-31
EP0188538A1 (fr) 1986-07-30
ZA855485B (en) 1986-03-26
JPS61502751A (ja) 1986-11-27
AU576884B2 (en) 1988-09-08
DK131586D0 (da) 1986-03-21
IL75853A0 (en) 1985-11-29
AU4608285A (en) 1986-02-25

Similar Documents

Publication Publication Date Title
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK316988A (da) Transdermalt farmaceutisk praeparat og dets anvendelse
DK265990D0 (da) Transdermal absorptionsdosisenhed til behandling af postmenopausesyndrom og fremgangsmaade til indgivelse
DK279890A (da) Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et laegemiddel til bekaempelse af tumorer
DK51493D0 (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK254887A (da) Salve til behandling af hudsygdomme
DK217585D0 (da) Farmaceutisk middel til behandling af neoplastiske sygdomstilstande
DK315484A (da) Farmaceutisk praeparat, specielt til behandling af diabetes og fedme
IT8048692A0 (it) Metodo terapeutico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo
DK164844C (da) Transdermalt effektivt topisk antiallergisk farmaceutisk middel indeholdende azatadin og anvendelse af azatadin til fremstilling af et saadant middel til topisk transdermal behandling af allergiske sygdomme
GB2087234B (en) Anticholinergic drugs/transdermal skin plasters
PT84933B (fr) Procede de preparation de cyclodepsipeptides et compositions pharmaceutiques qui les contiennent
DK360884D0 (da) Farmaceutiske og veterinaere midler til behandling af iskaemiskehjertelidelser
DK700588A (da) Farmaceutisk doseringsenhed til behandling af klimakteriesygdomme og osteoporose
DK10188A (da) Middel til behandling af virussygdomme
DK269986A (da) Fremgangsmaade til foroegelse af den transdermale afgivelse af laegemidler samt praeparat til transdermal administrering
DE3782594T2 (de) Arzneimittel zur transdermalen verabreichung von nicorandil.
DK441987A (da) Farmaceutisk praeparat til behandling af cerebral ischaemi
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
IT1187666B (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari
DK39584D0 (da) Anvendelse af nafazatrom til forebyggelse og behandling af diverse sygdomme, laegemidler indeholdende nafazatrom sa mt fremgangsmader til disses fremstilling
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
PT87555A (pt) Process for the preparation and isolation of human splein and of pharmaceutical compounds containing it
IT8467076A0 (it) Farmaco per la terapia dell apoplessia cerebrale e composizione farmaceutica che lo contiene
DK639088A (da) Laegemiddel til behandling af iskaemiske hjertesygdomme

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed